Kimberly-Clark Corp (KMB) has announced several strategic changes and developments recently. The company is divesting its
Global Tissue Unit in a bid to refocus portfolio, while it forms a strategic alliance with
Suzano, a new global tissue company. This $3.4 billion joint venture plays to both companies' strengths and is a significant step for KMB's transformation. In addition, KMB is transferring its U.S. Stock Exchange Listing to Nasdaq to mark the end of a 100+ year NYSE legacy. The company is also in the process of selling its international tissue business to Suzano for approximately $3.5 billion. This venture and divestment reflect KMB's shift to focus on high-margin personal care. In addition to the strategic partnerships, KMB announced plans to invest over
$2 Billion to expand US Manufacturing, accelerate innovation, and fuel growth. Despite these positive initiatives, they are near selling their
Kleenex Division outside North America and their earnings have been affected by cost-cutting initiatives. Yet, the stock is still seeing a significant boost in position by several Investors.
Kimberly-Clark Corp KMB News Analytics from Wed, 23 Oct 2024 07:00:00 GMT to Fri, 06 Jun 2025 16:00:02 GMT -
Rating 5
- Innovation -2
- Information 8
- Rumor -3
